Get the Stockscreener App
0.9122
7.11%
-0.0698
Pre-market:
.88
-0.0322
-3.53%
Revelation Biosciences Inc stock is traded at $0.9122, with a volume of 210.48K.
It is down -7.11% in the last 24 hours and down -31.93% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$0.982
Open:
$0.98
24h Volume:
210.48K
Relative Volume:
0.54
Market Cap:
$2.13M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.0491
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
-9.68%
1M Performance:
-31.93%
6M Performance:
-71.31%
1Y Performance:
-93.73%
1-Day Range:
$0.91
$1.0242
1-Week Range:
$0.91
$1.0867
52-Week Range:
$0.702
$20.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
0.9122 | 5.82M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.98B | 69.59M | 525.67M | 0.5197 |
Revelation Biosciences Inc Stock (REVB) Latest News
Using RSI to spot recovery in Revelation Biosciences Inc. Equity WarrantMarket Risk Summary & Stepwise Trade Execution Plans - newser.com
Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity WarrantWeekly Profit Analysis & Consistent Return Investment Signals - newser.com
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 - El Paso Times
Using flow based indicators on Revelation Biosciences Inc.July 2025 Institutional & Consistent Profit Alerts - newser.com
Chart based analysis of Revelation Biosciences Inc. Equity Warrant trendsGap Up & Weekly Market Pulse Updates - newser.com
Will Revelation Biosciences Inc. Equity Warrant stock outperform Dow Jones indexWeekly Profit Report & Fast Gain Stock Tips - newser.com
Revelation Biosciences Inc. stock retracement – recovery analysisMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Using data filters to optimize entry into Revelation Biosciences Inc.Rate Cut & Risk Adjusted Buy/Sell Alerts - newser.com
Can Revelation Biosciences Inc. stock continue upward trend2025 Top Gainers & Fast Entry Momentum Alerts - newser.com
What catalysts could drive Revelation Biosciences Inc. Equity Warrant stock higher2025 Market Outlook & Weekly High Conviction Ideas - newser.com
Why Revelation Biosciences Inc. stock could outperform in 2025Long Setup & Consistent Return Strategy Ideas - newser.com
Pattern recognition hints at Revelation Biosciences Inc. Equity Warrant upsideRecession Risk & Long-Term Safe Investment Plans - newser.com
Volume spikes in Revelation Biosciences Inc. stock – what they meanMarket Volume Summary & Free Verified High Yield Trade Plans - newser.com
How high can Revelation Biosciences Inc. Equity Warrant stock goWeekly Trade Recap & Intraday High Probability Alerts - newser.com
Is Revelation Biosciences Inc Equity Warrant a good long term investmentDividend Growth Stocks & Affordable Portfolio Trading - earlytimes.in
Published on: 2025-11-09 00:37:32 - newser.com
Revelation Biosciences Sees Losses Narrow And Cash Pile Grow - Finimize
Advanced analytics toolkit walkthrough for Revelation Biosciences Inc. Equity WarrantMarket Weekly Review & Community Supported Trade Ideas - newser.com
REVB Ready to Advance Groundbreaking Treatment - MSN
Published on: 2025-11-07 09:09:36 - newser.com
Best data tools to analyze Revelation Biosciences Inc. Equity Warrant stockPortfolio Risk Summary & High Win Rate Trade Tips - newser.com
Is Revelation Biosciences Inc. stock attractive for growth ETFsWeekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com
How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
Revelation Biosciences (REVB) Projected to Post Earnings on Friday - Defense World
Combining price and volume data for Revelation Biosciences Inc.Earnings Miss & Community Verified Trade Signals - newser.com
Revelation Biosciences Q3 net loss narrows to $1.9 mln - MarketScreener
Revelation Biosciences (NASDAQ: REVB) believes cash sufficient to fund operations through Q3 2026 - Stock Titan
Applying Elliott Wave Theory to Revelation Biosciences Inc.July 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com
How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesQuarterly Portfolio Review & Daily Momentum Trading Reports - newser.com
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):